Aspen City Attorney Kate Johnson said opening upvalley bus lanes for general traffic as a means to ease congestion would ...
The US Food and Drug Administration (FDA) is reviewing a petition to revoke the approval of Roche's top-selling drug ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today an invitation for U.S. based ...
A 2024 CMS rule now requires payers, including Medicare Advantage plans, Medicaid, CHIP and ACA exchange carriers, to publicly report prior authorization metrics for the first time. The public ...
Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...
A newly approved pill form of GLP-1 medication could revolutionize obesity treatment by offering a convenient alternative to ...
President Donald Trump’s White House ballroom won final approval from a key agency on Thursday, days after a federal judge ...
The U.S. Food and Drug Administration on Wednesday approved a second oral GLP-1 medication, giving adults eligible for weight ...
Wegovy pill, from Novo Nordisk, was the first oral GLP-1 drug to be approved by the FDA, in December 2025. Foundayo is the second. The first versions of GLP-1s were injectable drugs that people had to ...
The Food and Drug Administration's decision Wednesday means patients in the United States will soon have access to a second ...
Lilly says Foundayo was approved to treat obesity and can lead to long-term weight loss, alongside diet and exercise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results